Anti-IGF1R antibody prolongs the paralysis duration of the gastrocnemius muscles after botulinum toxin-A treatment (IMAGE)

Shimane University - Izumo Campus

Anti-IGF1R antibody prolongs the paralysis duration of the gastrocnemius muscles after botulinum toxin-A treatment

Caption

Antibody administration following saline or BTX administration at the beginning of the treatment. Anti-IGF1R antibody treatment is denoted as IGF1R and control IgG antibody treatment as control IgG. Data is presented as mean + standard deviation. *P0.05, ***P0.001, ****P0.0001, and P0.01 were calculated using two-way ANOVA followed by a Tukey's test. 

Credit

Prof. Masashi Fujitani from Shimane University, Japan (https://www.nature.com/articles/s41419-023-06128-w#Fig1)

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.